Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Clin Cases. May 26, 2024; 12(15): 2578-2585
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2578
Table 2 Changes in blood pressure, medication adherence, self-efficacy, and health beliefs between the two groups over time, mean ± SD
VariableIntervention group (n = 70)
Control group (n = 80)
Group-by-time interaction

Baseline
3 months
6 months
Baseline
3 months
6 months
P value
Systolic blood pressure (mmHg)149 ± 14136 ± 12a133 ± 11a150 ± 14145 ± 13143 ± 12< 0.001
Diastolic blood pressure (mmHg)91 ± 983 ± 8a81 ± 7a92 ± 989 ± 888 ± 7< 0.001
Medication adherence score (MMAS-8)6.2 ± 1.87.4 ± 1.1a7.6 ± 1.0a6.1 ± 1.86.5 ± 1.76.7 ± 1.6< 0.001
Self-efficacy score (SEMCDS)68.4 ± 1.772.4 ± 1.5a73.2 ± 1.4a68.0 ± 1.769.5 ± 1.670.0 ± 1.5< 0.001
Perceived benefits score (HHBS)16.8 ± 2.418.2 ± 2.2a18.5 ± 2.1a16.7 ± 2.417.0 ± 2.317.2 ± 2.2< 0.001
Perceived barriers score (HHBS)11.2 ± 3.19.8 ± 2.9a9.5 ± 2.8a11.3 ± 3.110.9 ± 3.010.7 ± 2.9< 0.001
Perceived susceptibility score (HHBS)14.6 ± 2.916.0 ± 2.7a16.3 ± 2.6a14.5 ± 2.915.0 ± 2.815.2 ± 2.7< 0.001
Perceived severity score (HHBS)15.4 ± 2.716.8 ± 2.5a17.1 ± 2.4a15.3 ± 2.715.8 ± 2.616.0 ± 2.5< 0.001